This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Eckerdt, F. Articles by Strebhardt, K. Search for Related Content PubMed PubMed Citation Articles by Eckerdt, F. Articles by Strebhardt, K. Related Collections Cellular Pathobiology Cellular Pathobiology: Proliferation, Senescence, and Death

Polo-Like Kinase 1: Target and Regulator of Anaphase-Promoting Complex/Cyclosome–Dependent Proteolysis

¹ Department of Pharmacology, University of Colorado School of Medicine, Denver, Colorado and ² Department of Gynecology and Obstetrics, Medical School, J.W. Goethe-University, Frankfurt, Germany

Requests for reprints: Frank Eckerdt, Department of Pharmacology, University of Colorado School of Medicine, 4200 East 9th Avenue, Denver, CO 80262. Phone: 303-315-7681; Fax: 303-315-7160; E-mail: Frank.Eckerdt{at}UCHSC.edu and Klaus Strebhardt, Department of Gynecology and Obstetrics, Medical School, J.W. Goethe-University, Theodor-Stern-Kai 7, 60590 Frankfurt, Germany. Phone: 49-69-63016894; Fax: 49-69-63016364; E-mail: Strebhardt{at}em.uni-frankfurt.de.

Polo-like kinase 1 (Plk1) is a key regulator of progression through mitosis. Although Plk1 seems to be dispensable for entry into mitosis, its role in spindle formation and exit from mitosis is crucial. Recent evidence suggests that a major role of Plk1 in exit from mitosis is the regulation of inhibitors of the anaphase-promoting complex/cyclosome (APC/C), such as the early mitotic inhibitor 1 (Emi1) and spindle checkpoint proteins. Thus, Plk1 and the APC/C control mitotic regulators by both phosphorylation and targeted ubiquitylation to ensure the fidelity of chromosome separation at the metaphase to anaphase transition. The mechanisms underlying the control of genomic stability by Plk1 are discussed in this review. (Cancer Res 2006; 66(14): 6895-8)

This article has been cited by other articles:

				J. A. J. Steen, H. Steen, A. Georgi, K. Parker, M. Springer, M. Kirchner, F. Hamprecht, and M. W. Kirschner Different phosphorylation states of the anaphase promoting complex in response to antimitotic drugs: A quantitative proteomic analysis PNAS, April 22, 2008; 105(16): 6069 - 6074. [Abstract] [Full Text] [PDF]

				F. Yang, D. G. Camp II, M. A. Gritsenko, Q. Luo, R. T. Kelly, T. R. W. Clauss, W. R. Brinkley, R. D. Smith, and D. L. Stenoien Identification of a novel mitotic phosphorylation motif associated with protein localization to the mitotic apparatus J. Cell Sci., November 15, 2007; 120(22): 4060 - 4070. [Abstract] [Full Text] [PDF]

				T. L. Schmit and N. Ahmad Regulation of mitosis via mitotic kinases: new opportunities for cancer management Mol. Cancer Ther., July 1, 2007; 6(7): 1920 - 1931. [Abstract] [Full Text] [PDF]